Silagan, Edelyn B.

HRN: 23-63-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2024
CEFUROXIME 1.5GM (VIAL)
09/10/2024
09/10/2024
IV
1.5gms
On Call To OR
For Elective TAHBSO
Waiting Final Action 
09/15/2024
CEFUROXIME 500MG (TAB)
09/15/2024
09/21/2024
PO
1 Tab
BId
Post Op Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: